Global dialysis provider Fresenius Medical Care has issued bonds with an aggregate principal amount of US$1.5bn across two tranches. The proceeds will be used for general corporate purposes, including the refinancing of outstanding indebtedness.
Europe's largest lab group Synlab continues to see huge COVID-19 driven growth with organic revenue doubling and EBITDA quadrupling in the first quarter. 92% of that growth came from COVID-19 testing.
Germany's third-largest hospital group Sana Kliniken has announced the layoff of over 1,000 employees, while number one Fresenius Helios is also cutting staff, as patient numbers fail to recover from Covid. Volumes are still lower than in 2019, Dr. Boris Augurzky tells HBI.
PE firm Gimv has upped its stake in German buy-and-build dental platform Gesellschaft für Praxisnachfolge in der Zahnmedizin (GPNZ). The market is the most fragmented in Europe.
Swedish telehealth company KRY tells HBI that it will soon launch its mental health offering across Europe and is considering a move into digital therapeutics after raising a $300m Series D. The company confirms its valuation is now above $2bn. Click here to see our telehealth report, and click here to see a profile of […]
EU countries have already earmarked over €47bn euros to spend on health care from the €672bn Recovery and Resilience Facility (RRF), the continent's centrepiece of COVID-19 recovery. Digital innovation, primary care and long-term care are clear spending priorities across the board. We should know the full allocations next week.
Life Healthcare's international division continued to make up for its sluggish core South African (SA) market in the last two quarters meaning it expects better results than SA-only competitor Netcare. German group Asklepios, the largest single-country hospital operator in Europe, saw a big loss in 2020 despite generous state support.
Europe's most funded digital therapeutics start-up Kaia Health has raised a $75m Series C bringing its total amount raised to date to over $100m. CEO Konstantin Mehl tells HBI it will be spent on building the commercial team in Germany and the States as well as developing its motion detection solution used for treating chronic pain on mobile phones.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.